One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma

ACS Appl Mater Interfaces. 2013 Aug 28;5(16):7995-8001. doi: 10.1021/am402082d. Epub 2013 Aug 2.

Abstract

Mesoporous silica nanoparticles (MSNs) have proved to be an effective carrier for controlled drug release and can be functionalized easily for use as stimuli-responsive vehicles. Here, a novel intelligent drug-delivery system (DDS), camptothecin (CPT)-loaded and doxorubicin (DOX)-conjugated MSN (CPT@MSN-hyd-DOX), is reported via a facile one-pot preparation for use in synergistic chemotherapy of glioblastoma. DOX was conjugated to MSNs via acid-labile hydrazone bonds, and CPT was loaded in the pores of the MSNs. At pH 6.5 (analogous to the pH in tumor tissues), a fast DOX release was observed that was attributed to the hydrolysis of the hydrazone bonds. In addition, a further burst release of DOX was found at pH 5.0 (analogous to the pH in lyso/endosomes of tumor cells), leading to a strong synergistic effect. In all, CPT and DOX could be delivered simultaneously into tumor cells, and this intelligent DDS has great potential for tumor-trigged drug release for use in the synergistic chemotherapy of tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Camptothecin / administration & dosage
  • Camptothecin / chemistry
  • Cell Line, Tumor
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry
  • Drug Delivery Systems*
  • Drug Synergism*
  • Glioblastoma / drug therapy*
  • Glioblastoma / pathology
  • Humans
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Porosity
  • Silicon Dioxide / administration & dosage
  • Silicon Dioxide / chemistry

Substances

  • Silicon Dioxide
  • Doxorubicin
  • Camptothecin